Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

Detalles Bibliográficos
Autores principales: Salmanton-García, Jon, Marchesi, Francesco, Glenthøj, Andreas, Bilgin, Yavuz M., van Praet, Jens, Dávila-Valls, Julio, Martín-Pérez, Sonia, Labrador, Jorge, van Doesum, Jaap, Falces-Romero, Iker, Farina, Francesca, Schönlein, Martin, Chanut, Mathilde, Petzer, Verena, Espigado, Ildefonso, Dargenio, Michelina, Aujayeb, Avinash, Sili, Uluhan, Serrano, Laura, Pinczés, László Imre, de Jonge, Nick, Soto-Silva, Andrés, Buquicchio, Caterina, Prezioso, Lucia, Marchetti, Monia, Meers, Stef, Busca, Alessandro, Corradini, Paolo, Hoenigl, Martin, Koehler, Philipp, Rahimli, Laman, Çolak, Gökçe Melis, Arellano, Elena, Wolf, Dominik, Gräfe, Stefanie, Ammatuna, Emanuele, Berg Venemyr, Caroline, Cornely, Oliver A., Pagano, Livio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605793/
https://www.ncbi.nlm.nih.gov/pubmed/36310756
http://dx.doi.org/10.1097/HS9.0000000000000789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605793/
https://www.ncbi.nlm.nih.gov/pubmed/36310756
http://dx.doi.org/10.1097/HS9.0000000000000789

Ejemplares similares